Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday
03:08pm, Wednesday, 07'th Sep 2022 Benzinga
Glaukos Corporation (NYSE: GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary effica
Why Verve Therapeutics Stock Crushed It This Week
04:30pm, Saturday, 27'th Aug 2022 The Motley Fool
The biotech's long-winded rally continued this week.
Why Verve Therapeutics Stock Crushed It This Week
12:30pm, Saturday, 27'th Aug 2022
The biotech's long-winded rally continued this week.
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
02:34pm, Thursday, 25'th Aug 2022 Benzinga
Upgrades
According to Goldman Sachs, the prior rating for FREYR Battery (NYSE:FREY) was changed from Neutral to Buy. In the second quarter, FREYR Battery showed an EPS of $0.24, compared to $0.04 from
Salesforce To $250? Here Are 5 Other Price Target Changes For Thursday
11:17am, Thursday, 25'th Aug 2022 Benzinga
Credit Suisse cut the price target on Salesforce, Inc. (NYSE: CRM) from $315 to $250. Credit Suisse analyst Phil Winslow maintained the stock with an Outperform rating. Salesforce shares fell 6.4%
Turquoise Hill Resources, Intuit And Some Other Big Stocks Moving Higher On Wednesday
02:52pm, Wednesday, 24'th Aug 2022 Benzinga
Turquoise Hill Resources Ltd. (NYSE: TRQ) climbed 25% to $29.14 after Rio Tinto Group raised its offer to buy out Turquoise Hill Resources.
Farfetch Limited (NYSE: FTCH) shares climbed 18.9% to $9.3
Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday
09:56am, Wednesday, 24'th Aug 2022 Benzinga
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares jumped 55.2% to close at $0.70 on Tuesday after the company announced it has entered into a global licensing agreement for the development an
Macy's, Palo Alto Networks And Other Big Gainers From Tuesday
09:19am, Wednesday, 24'th Aug 2022 Benzinga
U.S. stocks closed mostly lower with the Dow Jones dropping more than 150 points on Tuesday. Here is the list of some big stocks moving higher in the previous session.
Aerie Pharmaceuticals, Inc. (NA
Verve Therapeutics Highlights Preclinical Data Supporting Nomination of VERVE-201 ANGPTL3 Product Candidate at the European Society of Cardiology 2022 Congress
10:30am, Monday, 22'nd Aug 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-cours
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
10:30am, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.
Over $300 Million in Capital Added to Balance Sheet, Supporting an Operating Runway into Second Half of 2025
2 Biotech Stocks That Could Help Make You a Fortune
10:15am, Saturday, 30'th Jul 2022 The Motley Fool
These companies have seen triple-digit revenue growth in recent years.
Biotech Stock Roundup: BMY, BIIB's Q2 Earnings, GILD's Updates & More
03:15pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Earnings updates from Bristol Myers (BMY) and Biogen (BIIB) are a few key highlights from the biotech sector during the past week.
Verve Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
08:01pm, Monday, 25'th Jul 2022 GlobeNewswire Inc.
CAMBRIDGE, Mass., July 25, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc. (Nasdaq: VERV), a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-cour
Why Shares of Verve Therapeutics Shot Up 44.9% This Week
05:58pm, Friday, 22'nd Jul 2022 The Motley Fool
The gene-editing company is getting an infusion of cash.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
09:04am, Friday, 22'nd Jul 2022 Benzinga
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up peri
